Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000904454-17-000731
Filing Date
2017-12-14
Accepted
2017-12-14 12:07:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D/A FOR OCERA THERAPEUTICS, INC. BY DOMAIN PARTNERS VIII, L.P. s13da_121317-ocera.htm SC 13D/A 82706
  Complete submission text file 0000904454-17-000731.txt   84364
Mailing Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065
Business Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065 6504750158
Ocera Therapeutics, Inc. (Subject) CIK: 0001274644 (see all company filings)

EIN.: 631192270 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86177 | Film No.: 171255614
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE, SUITE 515 PRINCETON NJ 08542
Business Address C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE, SUITE 515 PRINCETON NJ 08542 609-683-5656
Domain Partners VIII, L.P. (Filed by) CIK: 0001465144 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: SC 13D/A